BroadPharm has filed a new non-provisional US patent for PEGylated Cyanines

BroadPharm has filed a new non-provisional US patent for PEGylated Cyanines

Published by BroadPharm on May 10, 2017

BroadPharm, a leading customer-focused biotech company, has filed a new patent which covers functionalized PEGylated cyanine compounds and their applications. The incorporation of PEG into cyanine dyes has greatly improved the dye's hydrophilicity. The introduction of a variety of functional groups broadens the applications of these cyanine dyes in biolabeling, imaging and other fields.

"The filing of this new patent will further strengthen BroadPharm's leading position in PEGylation and biolabeling field." said David Zhang, Chief Executive Officer of BroadPharm.

For products, go to http://bit.ly/2q4gX0L